Pain Management in Outpatient Urologic Procedures

Status Completed

Clinical Trial Summary

Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.

Clinical Trial Description

Patients will be approached in the pre-operative area prior to their outpatient urologic surgery. Informed Consent will be obtained at that time. Patients will be instructed that they will receive a prescription for either opioid pain medication or non-opioid medication for after surgery. The opioid medication includes oxycodone, while the non-opioid includes ketoralac, a non-steroidal anti-inflammatory medication. Subjects will be assigned randomly to either medication. Standard of care after outpatient urologic surgery is either oxycodone or ketoralac, however there is no previous research on whether one is superior than the other. These drugs were chosen because they are the most commonly used medications after outpatient urologic surgery. The study team and patients will not be blinded to the treatment.

They will also receive instructions for non-opioid pain management. If the patients require additional pain medication after surgery, they are instructed to call the provider's office for further evaluation and treatment. The patient's physician will prescribe further medication if warranted. The post-operative appointment is scheduled 2-3 weeks after surgery. At the post-operative appointment, patients will then be given a four question paper survey inquiring how well their pain was managed, how many pills were taken, if any additional non-opioid medications were taken for pain, and how the extra pills were disposed. Other PHI that will be collected includes patient's age, gender, past medical history, past surgical history, renal function, prior medications, and current surgery. ;

Study Design

Related Conditions & MeSH terms

Urologic Diseases

Clinical Trial Details

NCT number	NCT03393364
Study type	Interventional
Source	University Hospitals Cleveland Medical Center
Contact
Status	Completed
Phase	Early Phase 1
Start date	April 1, 2018
Completion date	June 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06397287` - PROM Project Urology
Completed	`NCT03572348` - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures.	N/A
Completed	`NCT03339609` - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children	N/A
Active, not recruiting	`NCT01529658` - Renal Hypothermia During Partial Nephrectomy	N/A
Completed	`NCT05082142` - Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)	Phase 4
Completed	`NCT03668262` - ED50 of Cis-atracurium for Laryngeal Mask Incubation in General Anesthesia
Recruiting	`NCT04763538` - Quality and Outcome Measurements of Urological Patients
Completed	`NCT05032287` - Medical Expulsive Therapy Post-SWL For Renal Stones	N/A
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Active, not recruiting	`NCT03243682` - The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones	N/A
Recruiting	`NCT05169892` - Aquablation in Benign Prostatic Hyperplasia in Canada
Enrolling by invitation	`NCT03234543` - Remote Ischemic Conditioning in Abdominal Surgery	N/A
Recruiting	`NCT05201131` - Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
Recruiting	`NCT06187870` - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Completed	`NCT03847909` - A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2	Phase 2
Recruiting	`NCT04972890` - The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction	Phase 2/Phase 3
Not yet recruiting	`NCT03258658` - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures	Phase 1
Terminated	`NCT02543645` - A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer	Phase 1
Terminated	`NCT03843073` - Connected Catheter- Safety and Effectiveness Study	N/A
Terminated	`NCT04826484` - Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel	Phase 3